Streptococcus equi virulence protein Eq85 (Eq85)

No reliable information identifies "Streptococcus equi virulence protein Eq85" as a recognized protein, receptor, or molecular target in Streptococcus equi subsp. equi, the causative agent of equine strangles. Extensive searches of genomic data, virulence factor studies, and structural analyses reveal no matches for "Eq85" among known S. equi proteins such as the M-like protein SeM (a major antiphagocytic factor), surface protein SEQ2190, phospholipases SlaA/SlaB, or lipoprotein SeLppC. S. equi virulence relies on core genes like those encoding SeM for immune evasion and plasmid-encoded factors in related pathogens like Rhodococcus equi (e.g., Vap family proteins such as VapA, VapG), but Eq85 lacks any documented sequence, structure, or functional role. This absence suggests the name may stem from a typographical error, obscure annotation, or confusion with non-S. equi elements like Rhodococcus equi VapG, a β-barrel virulence protein dispensible for intramacrophagic growth. Without validated data, Eq85 cannot be classified as a therapeutic target, and no drugs, biomarkers, or disease associations apply. Research on S. equi prioritizes validated antigens like SeM for vaccine development against strangles, a purulent lymphadenitis in horses.